An international research team led by Maggie Wong at the Max Planck Institute for Psycholinguistics (MPI) has discovered that ...

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

Founded to close Asia’s persistent “drug lag,” Renalys develops innovative therapies for chronic kidney disease across Japan and the region. The company has completed primary endpoint data collection ...

Chugai Pharma to acquire Tokyo-based clinical biopharmaceutical company, Renalys Pharma: Tokyo, Japan Saturday, October 25, 2025, 09:00 Hrs [IST] Renalys Pharma, Inc., a privately ...

Scientists have identified mutations in the CPD gene as a key cause of a rare congenital hearing loss, revealing how ...

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations affect mRNA and result in disease.

Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.

Some genetic disorders-such as cystic fibrosis, hemophilia and Tay Sachs disease-involve many mutations in a person's genome, often with enough variation that even two individuals who share the same ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...